Zantac and other heartburn drugs based on the generic drug ranitidine have been found to contain the carcinogenic compound NDMA (N-nitrosodimethylamine). This compound is classified as a potentially dangerous cancer-causing agent, and is used in gasoline, rocket fuel, as a stabilizer in industrial materials and as an additive to lubricants.
Zantac is sold by the maniufacturer Sanofi, as well as generically under the name ranitidine.
Lawsuits filed against the manufacturer maintain that Zantac contains levels of NDMA that are 26,000 times higher than the levels allowed by the FDA. In the recent past, several blood pressure medications that were found to contain the cancer-causing contaminant NDMA were recalled from the market.
According to studies of the contaminant NDMA (N-nitrosodimethylamine), possible side effects of ingestion are:
Our attorneys are investigating claims related to the the contamination of Zantac and generic heartburn drugs made from ranitidine. Filing a claim against the manufacturers of Zantac and generic ranitidine could help you recover compensation for:
If you or a loved one developed cancer after taking Zantac, please contact our Zantac Lawsuit Attorneys today for a free consultation. You may be entitled to significant monetary compensation. There is never a fee unless we recover for you.